COMMUNIQUÉS West-GlobeNewswire

Early Warning News Release
02/04/2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- This news release is being issued by Dr. Sven Grail (" Dr. Grail ") and Grail Family [...]
TeamHealth and Array Behavioral Care partner to transform emergency behavioral health treatment
02/04/2025
KNOXVILLE, Tenn., April 02, 2025 (GLOBE NEWSWIRE) -- TeamHealth , a physician-founded and led practice of 18,000 clinicians and operational team members partnering with more than 2,400 hospitals and facilities, today [...]
Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis
02/04/2025
MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis The trial did not meet its [...]
Sienna Announces First Quarter 2025 Results Release Date and Conference Call
02/04/2025
MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2025 first quarter results after market close on Tuesday, May 6 [...]
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
02/04/2025
BERWYN, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty & Rare [...]
AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services
02/04/2025
Tech-first therapy initiation and patient solutions provider enhances and augments services with artificial intelligence-powered patient engagement ORLANDO, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- AssistRx , the [...]
Sienna Senior Living Completes Previously Announced Acquisitions in Alberta and British Columbia
02/04/2025
MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a portfolio of four [...]
Polyrizon Engages Leading Branding Firm for Strategic Brand Development
02/04/2025
Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally [...]
Nice Healthcare Partners with Business Health Trust to Expand in Washington
02/04/2025
Bringing affordable in-home and virtual primary care to Seattle, Tacoma, Everett, and Spokane MINNEAPOLIS, April 02, 2025 (GLOBE NEWSWIRE) -- Employers know that offering the right benefits isn’t just about staying [...]
Hydreight Technologies Named One of the Americas’ Fastest Growing Companies by Financial Times
02/04/2025
VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth [...]
Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!
02/04/2025
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro biota, Prime Biome has swept the wellness industry. Prime Biome is the greatest option for safe , [...]
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
02/04/2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James [...]
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
02/04/2025
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that [...]
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
02/04/2025
JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , announced today that the FDA has approved an [...]
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
02/04/2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
02/04/2025
HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and [...]
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
02/04/2025
Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) -- Appili [...]
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
02/04/2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory [...]
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
02/04/2025
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated [...]

Pages